Genomic landscapes of cancers: prospects for targeted therapies.
Bleeker
Fonnet E
FE
Bardelli
Alberto
A
D058534:Class I Phosphatidylinositol 3-Kinases; D064211:Connectin; D066246:ErbB Receptors / Q000235:genetics; D023281:Genomics; D020662:Guanine Nucleotide Exchange Factors / Q000235:genetics; D006801:Humans; D009124:Muscle Proteins / Q000235:genetics; D009154:Mutation; D009369:Neoplasms / Q000235:genetics* / Q000628:therapy; D051059:PTEN Phosphohydrolase / Q000235:genetics; D019869:Phosphatidylinositol 3-Kinases / Q000235:genetics; D011494:Protein Kinases / Q000235:genetics; D017346:Protein Serine-Threonine Kinases; D064067:Rho Guanine Nucleotide Exchange Factors
D058534:Class I Phosphatidylinositol 3-Kinases; D064211:Connectin; D066246:ErbB Receptors; D020662:Guanine Nucleotide Exchange Factors; D009124:Muscle Proteins; D051059:PTEN Phosphohydrolase; D019869:Phosphatidylinositol 3-Kinases; D011494:Protein Kinases; D017346:Protein Serine-Threonine Kinases; D064067:Rho Guanine Nucleotide Exchange Factors; C577285:TTN protein, human; C484760:PIK3CA protein, human; C578224:OBSCN protein, human; C494929:PTEN protein, human